GENE ONLINE|News &
Opinion
Blog

RSV vaccines
GeneOnline’s Weekly News Highlights: Oct 22-Oct 27
2023-10-31
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Recent Highlights of the RSV Vaccine Battle, with More Regulatory Approvals in Sight
2023-06-08
GSK Wins Approval For World’s First RSV Vaccine
2023-05-08
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
The First Approved RSV Vaccine Worldwide Belongs to AstraZeneca and Sanofi
2022-11-06
GSK’s RSV Vaccine Candidate Has Won Another Regulatory Review
2022-11-03
GSK Posts Stellar Results from Phase 3 RSV Vaccine Trial
2022-10-13
AstraZeneca, Sanofi’s RSV Antibody Recommended For Approval In EU
2022-09-19
Pfizer’s Bivalent RSV Candidate Demonstrates 85% Efficacy in Phase 3 Trials
2022-08-26
ReViral Acquisition by Pfizer To Enhance Its Respiratory Syncytial Virus Therapeutic Portfolio
2022-04-10
LATEST
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Unveiling the Role of Microbes in Climate Change at COP28
2023-12-04
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
EVENT
Scroll to Top